Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 28, Number 6—June 2022
CME ACTIVITY - Synopsis

Cross-Sectional Study of Clinical Predictors of Coccidioidomycosis, Arizona, USA

Ferris A. RamadanComments to Author , Katherine D. Ellingson, Robert A. Canales, Edward J. Bedrick, John N. Galgiani, and Fariba M. Donovan
Author affiliations: University of Arizona, Tucson, Arizona, USA (F.A. Ramadan, K.D. Ellingson, E.J. Bedrick); George Washington University, Washington, DC, USA (R.A. Canales); University of Arizona College of Medicine–Tucson, Tucson (J.N. Galgiani, F.M. Donovan)

Main Article

Table 4

Characteristics of inpatients in univariable and multivariable models in a cross-sectional study of clinical predictors of coccidioidomycosis, Arizona, USA*

Characteristics Univariable model
 Multivariable model
OR (95% CI) p value aOR (95% CI) p value
Demographics
Age, y 0.70 (0.50–0.98) 0.035 0.72 (0.51–1.03) 0.071
Non-White race
 2.42 (1.16–5.04)
 0.018
2.14 (0.51–1.03)
 0.061
Symptoms
Muscle aches 0.45 (0.22–0.94) 0.034 0.38 (0.17–0.84) 0.017
Rash
 2.29 (1.08–4.84)
 0.030
2.20 (0.97–4.99)
 0.060
Clinical feature
Immunocompromised
 0.49 (0.25–0.94)
 0.033
0.64 (0.31–1.31)
 0.220
Laboratory tests
C-reactive protein, mg/L 0.66 (0.46–0.94) 0.023 0.72 (0.49–1.07) 0.100
Eosinophil count, × 103/µL 1.65 (1.17–2.34) 0.005 1.50 (1.02–2.19) 0.037
Total protein, g/dL 1.50 (1.08–2.08) 0.015 1.30 (0.91–1.87) 0.152

*Participants were recruited from among hospitalized patients, including 38 coccidioidomycosis-positive participants and 255 coccidioidomycosis-negative participants. Bold text indicates statistical significance. Bold text indicates statistical significance. aOR, adjusted odds ratio; OR, odds ratio.

Main Article

Page created: March 21, 2022
Page updated: May 20, 2022
Page reviewed: May 20, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external